Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,605,090
+$5,964 QoQ
Shares Held
6,320
-3.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
#2,534
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CALTON & ASSOCIATES, INC. holds $9,328,876 across 9 Drug Manufacturers - General names. JNJ ranks #2 (17.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,827 | $3,390,788 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
6,320 | $1,605,090 | |
| 3 | MRK |
Merck & Co., Inc.
|
9,693 | $1,245,550 | |
| 4 | ABBV |
AbbVie Inc.
|
4,822 | $1,213,408 | |
| 5 | PFE |
Pfizer Inc
|
26,875 | $647,150 | |
| 6 | AMGN |
Amgen Inc
|
1,111 | $402,315 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,244 | $302,159 | |
| 8 | GSK |
GSK plc
|
5,418 | $284,011 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,605,090 | 6,320 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,599,126 | 6,542 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,447,615 | 6,995 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,220,990 | 6,585 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $1,059,321 | 6,935 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $918,587 | 5,539 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $501,108 | 3,465 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $1,048,042 | 6,467 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $835,450 | 5,716 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $493,394 | 3,119 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $631,662 | 4,030 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $365,701 | 2,348 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $688,728 | 4,161 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $636,120 | 4,104 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $953,203 | 5,396 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $699,834 | 4,284 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $770,038 | 4,338 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $947,826 | 5,348 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $947,385 | 5,538 | Shares | Sole | 2022-01-13 | |
| 2021-09-30 | $1,166,030 | 7,220 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $1,308,529 | 7,943 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $1,371,665 | 8,346 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $1,583,872 | 10,064 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $1,646,315 | 11,058 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $1,655,636 | 11,773 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $1,753,863 | 13,375 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||